Hyperplasia of breast
Conditions
Interventions
Sponsors
Beijing Jifangtang Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. It meets the diagnostic criteria of western medicine for breast hyperplasia, and the course of disease is longer than 3 months; 2. Breast color ultrasound BI-RADS classification 2-3; 3. Aged over 18 years old; 4. Average VAS score for pain>=4, monthly pain days >=3 days, and target mass still exists on palpation; 5. Informed consent. Volunteers sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Women in pregnancy, lactation, menopause, severe menstrual cycle disorder or functional uterine bleeding; 2. Taking contraceptives and sex hormone drugs; 3. Patients with serious primary diseases of the heart, liver, kidney and hematopoietic system, or with mental illness; 4, Allergic constitution or allergy to the ingredients of this product; 5. Severe spinal injury, systemic skin disease, skin ulceration, cancer, life cycle less than three months, infectious diseases; 6. Those who plan to become pregnant within 3 months; 7. Alcoholics and/or psychoactive substances, drug abusers and dependents; 8. Those who are using Chinese and Western medicines for breast hyperplasia within one month or now before this treatment (including medicine for external application, acupuncture, etc.) and have not used hormone drugs within half a year; 9. Participated in other clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The size of mammary gland hyperplasia; | — |
Countries
China
Contacts
Public ContactMa Yibing
Beijing Jifangtang Academy of Traditional Chinese Medicine
Outcome results
None listed